XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Ordinary shares
Common stock
Paid-in capital
Retained earnings
Treasury shares
Employee Benefit Trust
Accumulated other comprehensive loss
Beginning balance at Jul. 31, 2023   $ 30 $ 0 $ 809 $ 8,557 $ (3,425) $ (46) $ (888)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Total other comprehensive income (loss), net of tax $ (34)              
Ending balance at Oct. 31, 2023               (922)
Beginning balance at Jul. 31, 2023   30 0 809 8,557 (3,425) (46) (888)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury shares canceled   0     0 0    
Ordinary shares canceled (in shares)   0   0        
Common stock issued     0       45  
Share-based compensation expense       44        
Net earnings 1,284       1,284      
Cash dividends declared         (472)      
Shares issued under employee stock plans         (68) 26    
Other       2     1  
Share repurchases           (351)    
Total other comprehensive income (loss), net of tax (26)             (26)
Ending balance at Apr. 30, 2024 5,522 30 0 855 9,301 (3,750) 0 (914)
Beginning balance at Oct. 31, 2023               (922)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Total other comprehensive income (loss), net of tax 25              
Ending balance at Jan. 31, 2024   30 0 842 9,018 (3,575) 0 (897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury shares canceled   0     0 0    
Ordinary shares canceled (in shares)   0   0        
Common stock issued     0       0  
Share-based compensation expense       13        
Net earnings 443       443      
Cash dividends declared         (160)      
Shares issued under employee stock plans         0 0    
Other       0     0  
Share repurchases           (175)    
Total other comprehensive income (loss), net of tax (17)             (17)
Ending balance at Apr. 30, 2024 5,522 30 0 855 9,301 (3,750) 0 (914)
Beginning balance at Jul. 31, 2024 5,616 30 0 864 9,589 (3,936) 0 (931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Total other comprehensive income (loss), net of tax (2)              
Ending balance at Oct. 31, 2024               (933)
Beginning balance at Jul. 31, 2024 5,616 30 0 864 9,589 (3,936) 0 (931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury shares canceled   (4)     (3,932) 3,936    
Ordinary shares canceled (in shares)   (26)   26        
Common stock issued     0       0  
Share-based compensation expense       30        
Net earnings 1,156       1,156      
Cash dividends declared         (488)      
Shares issued under employee stock plans         (84) 53    
Other       0     0  
Share repurchases           (767)    
Total other comprehensive income (loss), net of tax 15             15
Ending balance at Apr. 30, 2025 5,531 0 0 920 6,241 (714) 0 (916)
Beginning balance at Oct. 31, 2024               (933)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Total other comprehensive income (loss), net of tax (31)              
Ending balance at Jan. 31, 2025   0 0 912 5,998 (457) 0 (964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury shares canceled   0     0 0    
Ordinary shares canceled (in shares)   0   0        
Common stock issued     0       0  
Share-based compensation expense       8        
Net earnings 410       410      
Cash dividends declared         (164)      
Shares issued under employee stock plans         (3) 2    
Other       0     0  
Share repurchases           (259)    
Total other comprehensive income (loss), net of tax 48             48
Ending balance at Apr. 30, 2025 $ 5,531 $ 0 $ 0 $ 920 $ 6,241 $ (714) $ 0 $ (916)